- November 22, 2026
- Updated 8:26 am
The Controversial Rise of Kratom: A Double-Edged Sword
- 27 Views
- admin
- November 16, 2026
- Health Public Health
Kratom, a substance that interacts with opioid receptors, is as accessible as chips in some places. Derived from a Southeast Asian tree, locals have long consumed its leaves for a stimulating, tea-like brew with opioid-like effects.
The Growing Industry
In the U.S., kratom sales have created a lucrative industry. Products containing kratom are sold online and in numerous stores nationwide, including at gas stations. The industry promotes it as a mild stimulant and recovery aid for opioid addiction.
Kratom enjoys support at high government levels and remains legal in many states. However, health experts express concerns over potential addiction and fatal outcomes. Dr. Andrew Kolodny from Brandeis University highlights its effects, akin to oxycodone and heroin. The CDC reports kratom’s presence in over 5,000 overdose deaths from 2020-2024.
Advocacy and Concerns
The American Kratom Association, a consumer advocacy group, portrays kratom as a safe herbal supplement. They argue it offers energy and wellbeing benefits. Yet, four families shared with ’60 Minutes’ how their sons began using kratom seeking such benefits, only for it to contribute to their untimely deaths.
“He was looking for something for energy. A friend of his told him it was safer than Red Bull,” Wendy Chamberlain said about her son Joe.
In tragic instances, Matthew and Joe’s deaths linked solely to mitragynine, kratom’s main component. Others, like Daniel and Wyatt, involved mitragynine with other substances. Susan Eppard recounted her son’s sudden collapse during a card game and the emotional aftermath.
Analyzing Risks
Justin Brower, a toxicologist from NMS Labs, has analyzed numerous kratom-related fatalities. He notes a significant rise in such deaths since 2014. These fatalities have surged, capturing more attention.
The FDA warns against kratom use due to liver toxicity, seizures, and risk of addiction. Amid growing concern, the government signaled a restriction on kratom derivatives like 7-OH. Then, HHS altered its stance, permitting higher 7-OH levels, surprising health officials.
’60 Minutes’ discovered financial influences at play, with substantial sums from the American Kratom Association supporting lobbying efforts. Dr. Kolodny compared this to Purdue Pharma’s strategies with OxyContin. Political contributions and investments further complicate advocacy transparency.
Family Voices
While HHS declined an interview, it stated that decisions were uninfluenced by external pressures. The American Kratom Association distinguishes between natural and chemically altered kratom products.
Eppard remains bewildered that kratom is for sale, often informing store employees about its potential dangers. She fondly remembers her son, expressing the deep void his absence has left.